Research output per year
Research output per year
- 16 results
Search results
-
2022
Autologous cell therapy - A new concept to eradicate inhibitors in haemophilia
Xie, H., Ljung, R., Astermark, J. & Hylander, T., 2022 Nov, In: Haemophilia. 28, 6, p. e259-e261Research output: Contribution to journal › Letter › peer-review
Open Access -
Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders
Olsson, A., Westesson, L. M., Baghaei, F., Holmström, M., Olsson, E., Magnusson, M., Ranta, S., Astermark, J., Andersson, N. G., Thanner, J., Szamosi, J., Daoura, L. & Sennfält, K., 2022, (Accepted/In press) In: Haemophilia.Research output: Contribution to journal › Letter › peer-review
-
2021
Identification of F8 rearrangements in carrier and non-carrier mothers of haemophilia A patients
Manderstedt, E., Lind-Halldén, C., Ljung, R., Astermark, J. & Halldén, C., 2021, In: Haemophilia. 27, 5, p. 1-5Research output: Contribution to journal › Letter › peer-review
-
2020
Long-term follow-up of neonatal intracranial haemorrhage in children with severe haemophilia
Andersson, N. G., Wu, R., Carcao, M., Claeyssens-Donadel, S., Kobelt, R., Liesner, R., Mäkipernaa, A., Ranta, S., Ljung, R. & ICH study group, 2020 Jul, In: British Journal of Haematology. 190, 2, p. e101-e104 4 p.Research output: Contribution to journal › Letter › peer-review
-
2019
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
van den Berg, H. M., Fischer, K., Carcao, M., Chambost, H., Kenet, G., Kurnik, K., Königs, C., Male, C., Santagostino, E., Ljung, R. & PedNet Study Group, 2019 Jul 18, In: Blood. 134, 3, p. 317-320 4 p.Research output: Contribution to journal › Letter › peer-review
-
2015
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
Nijdam, A., Altisent, C., Carcao, M. D., Cid, A. R., Claeyssens-Donadel, S., Kurnik, K., Ljung, R., Nolan, B., Petrini, P., Platokouki, H., Rafowicz, A., Thomas, A. E. & Fischer, K., 2015, In: Haematologica. 100, 3, p. E84-E86Research output: Contribution to journal › Letter › peer-review
-
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
van den Berg, H. M. & Ljung, R., 2015, In: Blood. 126, 18, p. 2164-2165Research output: Contribution to journal › Letter › peer-review
-
2008
Female haemophilia A caused by skewed X inactivation
Knobe, K., Sjörin, E., Soller, M., Liljebjorn, H. & Ljung, R., 2008, In: Haemophilia. 14, 4, p. 846-848Research output: Contribution to journal › Letter
-
2003
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp, E., Astermark, J., Björkman, S., Blanchette, V. S., Fischer, K., Giangrande, P. L. F., Gringeri, A., Ljung, R., Manco-Johnson, M. J., Morfini, M., Kilcoyne, R. F., Petrini, P., Rodriguez-Merchan, E. C., Schramm, W., Shapiro, A., M Van Den Berg, H. & Hart, C., 2003, In: Haemophilia. 9, Suppl 1, p. 41278Research output: Contribution to journal › Letter › peer-review
File379 Downloads (Pure) -
2001
Optimal treatments for patients with bleeding disorders.
Brown, S. A., Aledort, L. M., Lee, C. A., Barrowcliffe, TW., Beeton, K., Blanchette, V., Bolland, S., Goddard, N., Goodeve, A., Hoyer, L., Kessler, C., Ljung, R., Lollar, P., Manco-Johnson, M., Mariani, G., Peerlinck, C. & Rivard, G., 2001, In: Haemophilia. 7, 3, p. 313-320Research output: Contribution to journal › Letter › peer-review
-
1994
High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]
Briet, E., Rosendaal, F. R., Kreuz, W., Rasi, V., Peerlinck, K., Vermylen, J., Ljung, R., Rocino, A., Addiego, J. & Lorenzo, J. I., 1994 Nov 25, In: Thrombosis and Haemostasis. 72, 1, p. 162-164Research output: Contribution to journal › Letter › peer-review
-
1992
Factor VIII and factor IX inhibitors in haemophiliacs
Ljung, R., Petrini, P., Lindgren, A. C., Tengborn, L. & Nilsson, I. M., 1992 Jun 20, In: The Lancet. 339, 8808, p. 1550-1551 2 p.Research output: Contribution to journal › Letter › peer-review
-
Further characterization of the new marker at DXS115 with regard to carrier detection in hemophilia A
Kling, S., Ljung, R., Sjörin, E. & Nilsson, I. M., 1992 Feb, In: Human Genetics. 88, 4, p. 484-485Research output: Contribution to journal › Letter › peer-review
-
1990
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate
Berntorp, E., Nilsson, I. M., Ljung, R. & Widell, A., 1990, In: The Lancet. 335, 8704, p. 1531Research output: Contribution to journal › Letter › peer-review
-
1988
Neutropenia and congenital cytomegalovirus infection
Ivarsson, S. A. & Ljung, R., 1988, In: Pediatric Infectious Disease Journal. 7, 6, p. 436-437 2 p.Research output: Contribution to journal › Letter
-
1982
Hemophilia B Leyden and a similar variant of hemophilia A.
Ljung, R. & Nilsson, I. M., 1982 Sep 30, In: New England Journal of Medicine. 307, 14, p. 897-898 2 p.Research output: Contribution to journal › Letter › peer-review